Skip to main content
Clinical Trials/CTRI/2025/05/086343
CTRI/2025/05/086343Not ApplicableNot Applicable

Effectiveness of Mobilization with Movement (MWM) Along with Usual Care for Knee Osteoarthritis: A Randomized Clinical Trial

Md Nazmul Huda1 site in 1 country50 target enrollmentStarted: May 15, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not Applicable
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
We used the Numerical Pain Rating Scale (NPRS) to measure pain intensity and a goniometer to measure joint angles. We use the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index to assess range of motion.

Study Overview

Brief Summary

Introduction Osteoarthritis (OA) is a common degenerative condition that primarily affects the knee joint. Osteoarthritis is defined as the gradual degradation of the cartilage in the joints, accompanied by changes in the bone underlying the cartilage, the synovial fluid, the ligaments, and the muscles around the affected area. Common manifestations of osteoarthritis (OA) include sensations of pain, stiffness, and decreased physical movement. The estimated worldwide incidence of OA is 16.0%. The treatment known as mobilization with movement (MWM) reduces pain and restores a full range of motion in the affected joint. Methods and analysis This study will be a randomized, single-blind controlled trial. A total of fifty adult patients diagnosed with knee osteoarthritis (OA) will be recruited. Participants will be randomly assigned to receive either mobilization with movement (MWM) treatment or conventional physiotherapy treatment. Outcome measures will include the Numerical Pain Rating Scale (NPRS) for assessing pain intensity, a goniometer for measuring joint range of motion, and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) for evaluating functional status. Assessments will be conducted at baseline (pre-test) and after the intervention (post-test). Ethics and dissemination The Institutional Review Board (IRB) of Bangladesh Health Professions Institute (BHPI) has approved the study. Every participant will give their informed consent, and only authorized people will have access to the anonymised data. The results of the study will be presented at conferences and in peer-reviewed journals.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
40.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients with knee OA who are diagnosed.
  • Age between 40 to 65 years (Koch, Sarma, Dutta, & Kalita, 2022).
  • Male and female both will be included (Alkhawajah, & Alshami, 2019).
  • Knee osteoarthritis affecting one or both knees, with a Kellgren and Lawrence grade of 2 or above (Kellgren, & Lawrence, 1957).
  • Patients undergoing physiotherapy at the musculoskeletal unit of CRP.

Exclusion Criteria

  • Knee or lower limb surgery.
  • Injection of corticosteroid or hyaluronic acid into the joint during the last 6 months (Alkhawajah, & Alshami, 2019).
  • Neurological diseases.
  • The individual experiences modified feelings about cold, heat, or pressure in the area of their knee (Alkhawajah, & Alshami, 2019).

Outcomes

Primary Outcomes

We used the Numerical Pain Rating Scale (NPRS) to measure pain intensity and a goniometer to measure joint angles. We use the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index to assess range of motion.

Time Frame: 6 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Md Nazmul Huda
Sponsor Class
Other [self-funded]
Responsible Party
Principal Investigator
Principal Investigator

Md Nazmul Huda

Bangladesh Health Professions Institute (BHPI)

Study Sites (1)

Loading locations...

Similar Trials